Painful eye metastasis from Stage IV gastric cancer
This gastric cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Adenocarcinoma
- Sex
- male
- Spread to
- bone, choroid of left eye
- Treatment
- chemotherapy, targeted therapy and surgery
- Outcome
- In Memory
Treatment course, step by step
- He received systemic oxaliplatin and cetuximab for Stage IV gastric cancer.
- When a painful choroidal metastasis caused severe visual problems, the left eye was surgically removed.
What happened, in summary
A man in his late 50s was diagnosed with Stage IV gastric cancer after imaging showed a stomach tumor and multiple bone metastases. Gastric biopsy confirmed moderately differentiated tubular adenocarcinoma. Because the disease was already metastatic, he did not undergo gastric surgery and instead received systemic treatment with oxaliplatin and cetuximab.
About a year after the gastric cancer diagnosis, he developed pain and worsening vision in his left eye. Eye examination showed retinal detachment, bleeding, and a mass in the choroid. CT and MRI supported a metastatic tumor rather than a primary eye melanoma. His left eye was surgically removed because of the painful, destructive lesion.
Pathology showed metastatic moderately differentiated adenocarcinoma. The staining pattern and his known gastric cancer supported the stomach as the origin, establishing choroidal metastasis from the gastric cancer. The procedure relieved his eye pain and he initially recovered from surgery. However, he died 2 months later. His course illustrates an uncommon but serious site of spread in already advanced gastric cancer, presenting with eye pain and visual disturbance.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Gastric Cancer 72 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer